Search

Your search keyword '"Agmon, V"' showing total 53 results

Search Constraints

Start Over You searched for: Author "Agmon, V" Remove constraint Author: "Agmon, V" Database MEDLINE Remove constraint Database: MEDLINE
53 results on '"Agmon, V"'

Search Results

2. WGS-Based Prediction and Analysis of Antimicrobial Resistance in Campylobacter jejuni Isolates From Israel.

3. A Snapshot of the Prevalence and Molecular Diversity of Legionella pneumophila in the Water Systems of Israeli Hotels.

4. Azithromycin non-susceptible Shigella circulating in Israel, 2014-2016.

5. Molecular typing of Cryptosporidium in Israel.

6. Dissemination of the Methicillin-resistant Staphylococcus aureus Pediatric Clone (ST5-T002-IV-PVL+) as a Major Cause of Community-associated Staphylococcal Infections in Bedouin Children, Southern Israel.

7. Genomic Epidemiology of Campylobacter jejuni Transmission in Israel.

8. Ambient temperature and age-related notified Campylobacter infection in Israel: A 12-year time series study.

9. Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel.

10. Real-time genomic investigation underlying the public health response to a Shiga toxin-producing Escherichia coli O26:H11 outbreak in a nursery.

11. Contribution of real-time PCR to Plasmodium species identification and to clinical decisions: a nationwide study in a non-endemic setting.

12. Molecular epidemiology of Campylobacter jejuni infection in Israel-a nationwide study.

13. Trends in the Epidemiology of Campylobacteriosis in Israel (1999-2012).

14. Near real-time space-time cluster analysis for detection of enteric disease outbreaks in a community setting.

15. Design and application of a core genome multilocus sequence typing scheme for investigation of Legionnaires' disease incidents.

16. Recent trends in the epidemiology of shigellosis in Israel.

17. Greywater use in Israel and worldwide: standards and prospects.

18. Integrative analysis of Salmonellosis in Israel reveals association of Salmonella enterica Serovar 9,12:l,v:- with extraintestinal infections, dissemination of endemic S. enterica Serovar Typhimurium DT104 biotypes, and severe underreporting of outbreaks.

19. Risk factors for sporadic infection with Salmonella Infantis: a matched case-control study.

20. Increased incidence of Campylobacter spp. infection and high rates among children, Israel.

21. Geographical variations in Salmonella incidence in Israel 1997-2006: the effect of rural residency.

22. Virulence gene profiling and pathogenicity characterization of non-typhoidal Salmonella accounted for invasive disease in humans.

23. Recent trends in the epidemiology of non-typhoidal Salmonella in Israel, 1999-2009.

24. Curtailed short-term and long-term survival following infection with non-typhoid Salmonella in Israel.

25. Multidrug-resistant Salmonella enterica serovar Infantis, Israel.

26. The epidemiology of extraintestinal non-typhoid Salmonella in Israel: the effects of patients' age and sex.

27. The changing panorama of bacterial enteric infections.

28. A survey of laboratory-confirmed isolates of invasive listeriosis in Israel, 1997-2007.

29. Salmonella enterica outbreak in a banqueting hall in Jerusalem: the unseen hand of the epidemiological triangle?

30. Clinical characteristics and molecular subtyping of Vibrio vulnificus illnesses, Israel.

31. Prevalence and correlates of diphtheria toxoid antibodies in children and adults in Israel.

32. Salmonella enterica serotype Virchow: epidemiology, resistance patterns and molecular characterisation of an invasive Salmonella serotype in Israel.

33. Blood invasiveness of Salmonella enterica as a function of age and serotype.

34. Endemic occurrence of infections by multidrug-resistant Escherichia coli of four unique serotypes in the elderly population of Israel.

35. Variability of Shigella flexneri serotypes in Israel during a period of two years: 2000 and 2001.

36. Microspectrofluorometry and fluorescence imaging in the study of human cytopathology.

37. Synthesis of fluorescent substrates and their application to study of sphingolipid metabolism in vitro and in intact cells.

38. Clinical, epidemiological, and microbiological features of Vibrio vulnificus biogroup 3 causing outbreaks of wound infection and bacteraemia in Israel. Israel Vibrio Study Group.

39. Multiprobe fluorescence imaging and microspectrofluorimetry of cell transformation and differentiation: implications in terms of applied biochemistry and biotechnology.

40. Nontyphoid Salmonella bacteremia: age-related differences in clinical presentation, bacteriology, and outcome.

41. Emergence of multidrug-resistant Salmonella enterica serotype Typhimurium phage-type DT104 among salmonellae causing enteritis in Israel.

42. Photosensitized inactivation of Plasmodium falciparum- and Babesia divergens-infected erythrocytes in whole blood by lipophilic pheophorbide derivatives.

43. Overexpression of human glucocerebrosidase containing different-sized leaders.

44. Intracellular degradation of sulforhodamine-GM1: use for a fluorescence-based characterization of GM2-gangliosidosis variants in fibroblasts and white blood cells.

45. Fluorescence-based selection of retrovirally transduced cells in the absence of a marker gene: direct selection of transduced type B Niemann-Pick disease cells and evidence for bystander correction.

46. Sulforhodamine GM1-ganglioside: synthesis and physicochemical properties.

47. Synthesis and use of novel fluorescent glycosphingolipids for estimating beta-glucosidase activity in vitro in the absence of detergents and subtyping Gaucher disease variants following administration into intact cells.

48. Diagnosing sphingolipidoses in murine and human embryos.

49. A novel fluorescent pH indicator for the acidic range.

50. Administration of pyrene lipids by receptor-mediated endocytosis and their degradation in skin fibroblasts.

Catalog

Books, media, physical & digital resources